• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Rekvina Labs Ltd Trading

  • Indian Private
  • BSE Code : 3082.0
  • ISIN : INE092O01028
59.40 1 (1.99%)
  • As on 13 Sep 2026 (EOD)

  • Today’s Low

    59.30

  • Today’s High

    59.40

  • Open

    59.40

  • Perv Close

    58.24

  • 52W Low

    6.75

  • 52W High

    59.40

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    66.03

  • Div & Yield %

    0.00

  • Book Value(₹)

    3.47

  • Debt-Equity Ratio

    1.99

  • AGM Date

    11-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    66.03

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.56

  • BV (₹)

    3.50

  • Sales( ₹ in Cr.)

    1.27

  • NP (in Cr.)

    -0.25

  • NP Var(%)

    -86.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -0.20

  • Traded Value (₹ in Lakhs)

    66.03

  • 52 Week High

    59.40

  • 52 Week Low

    6.75

  • Price BSE

    59.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    66.03

  • P/C Ratio

    -257.50

  • P/E Ratio

    -257.50

  • Price Vs.BV

    -0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1.27 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1.27 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1.27 0.00 0.00 0.00 0.00 0.00
EXPENDITURE :            
Raw Materials 1.18 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.23 0.04 0.00 0.00 0.00 0.00
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.11 0.09 0.02 0.00 0.08 0.04
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.03
Employee Benefit Expenses 0.23 0.04 0.00 0.00 0.00 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1.52 0.14 0.02 0.00 0.08 0.06
Operating Profit -0.25 -0.14 -0.02 0.00 -0.08 -0.06
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit -0.25 -0.14 -0.02 0.00 -0.08 -0.06
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax -0.25 -0.14 -0.02 0.00 -0.08 -0.06
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.25 -0.14 -0.02 0.00 -0.08 -0.06
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -0.25 -0.14 -0.02 0.00 -0.08 -0.06
Adjustment below Net Profit -0.64 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -3.35 -3.21 -3.19 -3.04 -2.96 -2.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -4.24 -3.35 -3.21 -3.04 -3.04 -2.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.42 -0.23 -0.03 0.00 -0.13 -0.11
Earnings Per Share(Adj)-Unit Curr -0.42 - - - - -0.11
Book Value -2.04 -0.55 -0.32 0.02 0.02 0.15
Book Value(Adj)-Unit Curr -2.04 - - - - 0.15

Shareholding Pattern

  • Promoter Group

    77.00%

  • Public Share Holding

    23.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,559,096 77.00 8,559,096 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,559,096 77.00 8,559,096 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 5,195 0.05 5,195 3
Clearing Members 4,000 0.04 4,000 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,000 0.01 1,000 1
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 424,324 3.82 164,124 16
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,020,470 9.18 1,020,470 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,087,610 9.78 459,210 2,424
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,556,654 23.00 1,660,654 2,451
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,115,750 100.00 10,219,750 2,457

Company Background

Rekvina Labs LtdTrading

  • Rekvina Labs Ltd
  • BSE Code : 3082.0
  • ISIN : INE092O01028

  • Incorporation Year

    1988

  • Registered Office

    328 Paradise Complex
    Sayajigunj, Vadodara,
    Gujarat-390005

  • Telephone

    91-265-2362966

  • FAX

  • Chairman

    ILA RAJENDRA PATHAK

  • Managing Director

    Amit Mukeshbhai Shah

  • Company Secretary

    Deepak Khandelwal

  • Auditor

    Y M Shah & Co

  • Face Value

    5

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Rekvina Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Rekvina Labs 59.40 1.27 1.27 -191.61 0.00
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77